Soft robotics breakthrough manages immune response for implanted devices

Discovery could enable longer-lasting and better-functioning devices — including pacemakers, breast implants, biosensors, and drug delivery devices.

Institute for Medical Engineering and Science • mit
Sept. 4, 2019 ~5 min

Unmasking mutant cancer cells

A new dosing regimen for an old cancer drug shows new promise as an immunotherapy.

Bendta Schroeder | Koch Institute • mit
July 17, 2019 ~5 min


New vaccine strategy boosts T-cell therapy

Super-charging a treatment for leukemia also makes it effective on solid tumors.

Anne Trafton | MIT News Office • mit
July 11, 2019 ~7 min

MGH: E-consults can streamline, simplify care and reduce need for visits

Mass. General researchers have found that electronic consultations in allergy and immunology can simplify the process of providing the most appropriate care, often reducing the need for in-person specialist visits.

Sue McGreevey • harvard
June 12, 2019 ~6 min

Mass. General researchers develop 3-D ‘mini-gut’ model to study response to gluten

Researchers at Massachusetts General Hospital have created miniature, simplified versions of the intestine in vitro to explore how the gut lining and microbiome respond to gluten in both healthy and celiac patients.

Susie Flaherty • harvard
May 9, 2019 ~4 min

A new approach to targeting tumors and tracking their spread

Researchers develop nanosized antibodies that home in on the meshwork of proteins surrounding cancer cells.

Helen Knight | MIT News correspondent • mit
May 6, 2019 ~7 min

“Inactive” ingredients may not be, study finds

Most pills contain compounds with potential to cause allergic reactions or discomfort in some patients.

Anne Trafton | MIT News Office • mit
March 13, 2019 ~8 min

Interaction between immune factors triggers cancer-promoting chronic inflammation

Harvard researchers found that interaction between immune factors triggers cancer-promoting chronic inflammation, setting the stage for the development of skin cancer associated with chronic dermatitis and colorectal cancer in patients with colitis.

Sue McGreevey • harvard
Feb. 11, 2019 ~4 min


New method improves transplant safety in mice

The combination of the antibody CD117 and the drug saporin selectively targets blood stem cells, making transplantation safer by limiting collateral damage caused by the current standard of treatment, chemotherapy, and radiation.

Harvard Gazette • harvard
Feb. 7, 2019 ~6 min

Epidemic of autoimmune diseases pushes researchers in new direction

Scientists at the Harvard Stem Cell Institute are seeking ways to protect newly transplanted cells from autoimmune attack.

Jessica Lau • harvard
Jan. 31, 2019 ~7 min

/

10